PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

So Cannacord sold out pre-announcement but brought back in post...

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    So Cannacord sold out pre-announcement but brought back in post announcement; Other instos sold into the increased liquidity driving price back to $1.35 (potential CR partners); PAR ended up on goldmans/CLSA's radar, breaking through the $1.30 support and pushing the SP into basement bargain territory. Reported data does not support heavy short selling, so maybe TA/FA triggered a sell off Wednesday onwards. May have to wait for this to wash through perhaps? or will instos see value in PAR at these prices. Will be interesting to see the data for 06.04.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.